295 related articles for article (PubMed ID: 37583655)
21. PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis.
Millán-de-Meer M; Luque-Ramírez M; Nattero-Chávez L; Escobar-Morreale HF
Hum Reprod Update; 2023 Nov; 29(6):741-772. PubMed ID: 37353908
[TBL] [Abstract][Full Text] [Related]
22. Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies.
Cassar S; Misso ML; Hopkins WG; Shaw CS; Teede HJ; Stepto NK
Hum Reprod; 2016 Nov; 31(11):2619-2631. PubMed ID: 27907900
[TBL] [Abstract][Full Text] [Related]
23. Lifestyle changes in women with polycystic ovary syndrome.
Moran LJ; Hutchison SK; Norman RJ; Teede HJ
Cochrane Database Syst Rev; 2011 Jul; (7):CD007506. PubMed ID: 21735412
[TBL] [Abstract][Full Text] [Related]
24. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.
Cooney LG; Lee I; Sammel MD; Dokras A
Hum Reprod; 2017 May; 32(5):1075-1091. PubMed ID: 28333286
[TBL] [Abstract][Full Text] [Related]
25. Quantitative risk-benefit profiles of oral contraceptives, insulin sensitizers and antiandrogens for women with polycystic ovary syndrome: A model-based meta-analysis.
Tang Z; Guan J; Mao JH; Han L; Zhang JJ; Chen R; Jiao Z
Eur J Pharm Sci; 2023 Nov; 190():106577. PubMed ID: 37666459
[TBL] [Abstract][Full Text] [Related]
26. The effects of metformin on endogenous androgens and SHBG in women: a systematic review and meta-analysis.
Barba M; Schünemann HJ; Sperati F; Akl EA; Musicco F; Guyatt G; Muti P
Clin Endocrinol (Oxf); 2009 May; 70(5):661-70. PubMed ID: 19178532
[TBL] [Abstract][Full Text] [Related]
27. Statins for women with polycystic ovary syndrome not actively trying to conceive.
Raval AD; Hunter T; Stuckey B; Hart RJ
Cochrane Database Syst Rev; 2011 Oct; (10):CD008565. PubMed ID: 21975784
[TBL] [Abstract][Full Text] [Related]
28. Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome.
Sharpe A; Morley LC; Tang T; Norman RJ; Balen AH
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD013505. PubMed ID: 31845767
[TBL] [Abstract][Full Text] [Related]
29. The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials.
Melin J; Forslund M; Alesi S; Piltonen T; Romualdi D; Spritzer PM; Tay CT; Pena A; Witchel SF; Mousa A; Teede H
Eur J Endocrinol; 2023 Aug; 189(2):S37-S63. PubMed ID: 37536294
[TBL] [Abstract][Full Text] [Related]
30. Do Pleiotropic Effects of Spironolactone in Women with PCOS Make it More than an Anti-androgen? Evidence from a Systematic Review and Meta-analysis.
Bashir R; Asrar MM; Shah IA; Wani IA; Ganie MA
Curr Pharm Des; 2023; 29(19):1486-1496. PubMed ID: 36999713
[TBL] [Abstract][Full Text] [Related]
31. Anti-obesity pharmacological agents for polycystic ovary syndrome: A systematic review and meta-analysis to inform the 2023 international evidence-based guideline.
Goldberg A; Graca S; Liu J; Rao V; Witchel SF; Pena A; Li R; Mousa A; Tay CT; Pattuwage L; Teede H; Yildiz BO; Ee C
Obes Rev; 2024 May; 25(5):e13704. PubMed ID: 38355887
[TBL] [Abstract][Full Text] [Related]
32. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource.
Azziz R; Kintziger K; Li R; Laven J; Morin-Papunen L; Merkin SS; Teede H; Yildiz BO
Hum Reprod; 2019 Nov; 34(11):2254-2265. PubMed ID: 31751476
[TBL] [Abstract][Full Text] [Related]
33. Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments.
van Zuuren EJ; Fedorowicz Z
Br J Dermatol; 2016 Jul; 175(1):45-61. PubMed ID: 26892495
[TBL] [Abstract][Full Text] [Related]
34. Does metformin improve reproduction outcomes for non-obese, infertile women with polycystic ovary syndrome? Meta-analysis and systematic review.
Magzoub R; Kheirelseid EAH; Perks C; Lewis S
Eur J Obstet Gynecol Reprod Biol; 2022 Apr; 271():38-62. PubMed ID: 35149444
[TBL] [Abstract][Full Text] [Related]
35. Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.
Gambineri A; Pelusi C; Genghini S; Morselli-Labate AM; Cacciari M; Pagotto U; Pasquali R
Clin Endocrinol (Oxf); 2004 Feb; 60(2):241-9. PubMed ID: 14725687
[TBL] [Abstract][Full Text] [Related]
36. Combined oral contraceptives plus spironolactone compared with metformin in women with polycystic ovary syndrome: a one-year randomized clinical trial.
Alpañés M; Álvarez-Blasco F; Fernández-Durán E; Luque-Ramírez M; Escobar-Morreale HF
Eur J Endocrinol; 2017 Nov; 177(5):399-408. PubMed ID: 28912358
[TBL] [Abstract][Full Text] [Related]
37. Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis.
Skiba MA; Islam RM; Bell RJ; Davis SR
Hum Reprod Update; 2018 Nov; 24(6):694-709. PubMed ID: 30059968
[TBL] [Abstract][Full Text] [Related]
38. Inositol for subfertile women with polycystic ovary syndrome.
Showell MG; Mackenzie-Proctor R; Jordan V; Hodgson R; Farquhar C
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012378. PubMed ID: 30570133
[TBL] [Abstract][Full Text] [Related]
39. The effectiveness and safety of treatments used for polycystic ovarian syndrome management in adolescents: a systematic review and network meta-analysis protocol.
Al Khalifah RA; Flórez ID; Dennis B; Neupane B; Thabane L; Bassilious E
Syst Rev; 2015 Sep; 4():125. PubMed ID: 26420636
[TBL] [Abstract][Full Text] [Related]
40. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
Fertil Steril; 2018 Aug; 110(3):364-379. PubMed ID: 30033227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
